← Open Payments lookup

MARIA REIS: Open Payments

NPI 1124195680 · PLYMOUTH MEETING, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,515 in 79 payments from 10 companies in 2025. Trend: 2023 $1,498 · 2024 $864 · 2025 $1,515

Food & beverage: $1,515
CompanyPaymentsAmount
Otsuka America Pharmaceutical, Inc.24$355
Neurocrine BioSciences, Inc.5$206
Collegium Pharmaceutical, Inc.12$204
Teva Pharmaceuticals USA, Inc.10$204
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)8$203
Supernus Pharmaceuticals, Inc.11$202
Alkermes, Inc.2$42
E.R. Squibb & Sons, L.L.C.2$39
Lundbeck LLC2$36
Corium, LLC3$25

Products named: INGREZZA, Jornay PM, CAPLYTA, Qelbree, REXULTI, UZEDY, ABILIFY ASIMTUFII, ABILIFY MAINTENA.

Industry payments across PA — which companies pay providers there.